Teva North America is comprised of subsidiaries of Teva Pharmaceutical Industries Ltd. In North America, Teva has locations in 13 states, the District of Columbia, Canada and Puerto Rico and more than 9,000 employees. In fact, one in every seven prescriptions dispensed in the U.S. and one in every seven dispensed in Canada is a Teva product.

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is a leading global pharmaceutical company, committed to providing consumers with access to high-quality healthcare by developing, producing and marketing affordable generic, innovative and specialty products, as well as active pharmaceutical ingredients.

The Company is the largest maker of generic pharmaceutical products, has a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. The branded businesses focus on CNS, oncology, pain, respiratory, women’s health and biologics.